Elie Dib

Elie Dib is a Lecturer at Johns Hopkins University, actively contributing to graduate programs including the MS in Bioinformatics, MS in Biotechnology, and MS in Individualized Genomics and Health. As a board-certified hematologist-oncologist based in Michigan, his research focuses on immunogenomics and the application of innovative therapies such as immunotherapy and targeted therapy in cancer treatment. He is also deeply involved in clinical research through national committees and editorial roles.

• Johns Hopkins University: Lecturer in Biotechnology Education
• St. Joseph Mercy Hospital: Associate Program Director for Hematology Oncology Fellowship
• Michigan Cancer Research Consortium: Deputy Principal Investigator

Education:

• University of Rochester: Hematology-Oncology training
• Harvard Medical School: Postgraduate work in cancer biology, immunotherapy, and genomics
• Johns Hopkins University: Master of Science in Individualized Genomics and Health

Research Focus: Elie Dib’s expertise lies at the intersection of cancer genomics and immunotherapy, with a particular emphasis on applying molecular profiling to guide targeted treatments. His work spans clinical trial leadership, translational research in genitourinary cancers, and the development of precision oncology strategies.

Publications & Clinical Impact: His recent articles (2023–2019) demonstrate a consistent contribution to precision medicine, particularly in ERBB2-targeted therapies, CDKN2A alterations in NSCLC, and immune checkpoint inhibitors in prostate cancer. These works reflect his engagement with national clinical trial networks like TAPUR and the Alliance for Clinical Trials in Oncology.

• Leadership Roles:
  • National Cancer Institute’s Genitourinary Cancers Steering Committee
  • Alliance for Clinical Trials in Oncology: Community Vice Chair (Immuno-Oncology Committee)
  • ASCO TAPUR Study molecular tumor board
  • Associate Editor, ASCO Self Educational Program
• Institutional Affiliations:
  • St. Joseph Mercy Hospital (Ann Arbor, MI)
  • Michigan Cancer Research Consortium